Which of the following markers has significant association with poor prognosis in traumatic brain injury?
**Core Concept**
Traumatic brain injury (TBI) is a complex condition involving various molecular and cellular mechanisms leading to secondary brain damage. Biomarkers play a crucial role in predicting outcomes and guiding clinical management. The question focuses on identifying a marker associated with a poor prognosis in TBI.
**Why the Correct Answer is Right**
The correct answer is **S100B protein**. Elevated S100B levels in the blood have been consistently linked to poor outcomes in TBI patients, including increased risk of mortality, neurological deficits, and cognitive impairment. S100B is a calcium-binding protein primarily found in astrocytes, and its release into the bloodstream following brain injury serves as a marker of astrocytic damage and neuronal degeneration. The mechanism involves the disruption of the blood-brain barrier, allowing S100B to leak into the systemic circulation.
**Why Each Wrong Option is Incorrect**
* **Option A:** C-reactive protein (CRP) is an acute-phase reactant that rises in response to systemic inflammation, but it is not specific to TBI and is not a reliable predictor of prognosis.
* **Option B:** N-terminal pro b-type natriuretic peptide (NT-proBNP) is a marker of cardiac stress and is not directly related to the pathophysiology of TBI.
* **Option C:** Interleukin-6 (IL-6) is a cytokine involved in the inflammatory response, but its levels are not as strongly correlated with TBI outcomes as S100B.
**Clinical Pearl / High-Yield Fact**
In the context of TBI, S100B levels are a valuable prognostic marker, and serial measurements can help monitor the progression of brain injury.
**Correct Answer:** B. S100B protein.